Compounded medications, if prescribed, are not FDA-approved and may be prepared by state-licensed 503A compounding pharmacies based on individual patient needs
Apperley L, Parkinson J, Senniappan S
GLP-1 drugs are expensive, with list prices exceeding $1,000/month in many markets, and studies consistently show that people who stop taking semaglutide regain roughly two-thirds of the weight they lost, raising fundamental questions about whether these drugs represent treatment or lifelong pharmaceutical dependency
But this should be done carefully
Over the last 10 years, prescribing GLP-1RAs has become increasingly prevalent due to their significant impact on diabetes disease control, weight loss, and cardiovascular disease risk reduction
10.1038/nature11066 Nature 47 JeulinC.LewinL